No Data
canature health technology (300272): Overseas revenue contributes to the basic level of performance, which is affected by the losses of its subsidiaries.
The company's income performance fell short of expectations. canature health technology achieved revenue of 1.254 billion yuan in Q1-3 2024, a year-on-year increase of 1%; achieved net income attributable to the mother of 0.084 billion yuan, a year-on-year decrease of 35%; achieved non-net profit attributable to the mother of 0.81 billion yuan.
Canature Health Technology (300272): Operations stable, non-operational drag on performance.
Event overview The company released the third quarter report of 2024: 24Q1-Q3: total operating income of 1.254 billion yuan (YOY +1.00%), net income attributable to the parent company of 0.084 billion yuan (YOY-34.92%), after deducting non-recurring items.
Kaineng Health: Report for the third quarter of 2024
Canature Health Technology (300272.SZ) released performance for the first three quarters, with a net income of 84.165 million yuan, a decrease of 34.92%.
canature health technology (300272.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 1...
Express News | Midday Announcement
Express News | Announcement Summary at Noon on September 4th: Canature Health Technology changes the source of convertible bonds to prioritize the use of repurchased shares.
No Data
No Data